These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18339181)

  • 21. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase.
    Aguilera B; Ghauharali-van der Vlugt K; Helmond MT; Out JM; Donker-Koopman WE; Groener JE; Boot RG; Renkema GH; van der Marel GA; van Boom JH; Overkleeft HS; Aerts JM
    J Biol Chem; 2003 Oct; 278(42):40911-6. PubMed ID: 12890686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.
    Elmonem MA; Abdelazim AM
    Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch.
    Auwerda JJ; Leebeek FW; Wilson JH; van Diggelen OP; Lam KH; Sonneveld P
    Transfusion; 2006 Oct; 46(10):1705-11. PubMed ID: 17002626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaucher disease and other storage disorders.
    Grabowski GA
    Hematology Am Soc Hematol Educ Program; 2012; 2012():13-8. PubMed ID: 23233555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease.
    Vissers JP; Langridge JI; Aerts JM
    Mol Cell Proteomics; 2007 May; 6(5):755-66. PubMed ID: 17293593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biology of the Gaucher cell: the cradle of human chitinases.
    Bussink AP; van Eijk M; Renkema GH; Aerts JM; Boot RG
    Int Rev Cytol; 2006; 252():71-128. PubMed ID: 16984816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lysosomal storage diseases: A brief summary].
    Bornemann A; Harzer K
    Pathologe; 2015 Sep; 36(5):485-93. PubMed ID: 26314267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.
    van der Lienden MJC; Gaspar P; Boot R; Aerts JMFG; van Eijk M
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30586924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum protein profile analysis in lysosomal storage disorders patients.
    López de Frutos L; García-González E; García-Rodríguez B; González-Irazabal Y; Lahoz C; Irún P; Cebolla JJ; Giraldo P
    Clin Chim Acta; 2020 Nov; 510():430-436. PubMed ID: 32745579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current and future biochemical markers for Gaucher disease].
    Froissart R
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S22-5. PubMed ID: 16644397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
    Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV
    Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
    Boot RG; Verhoek M; de Fost M; Hollak CE; Maas M; Bleijlevens B; van Breemen MJ; van Meurs M; Boven LA; Laman JD; Moran MT; Cox TM; Aerts JM
    Blood; 2004 Jan; 103(1):33-9. PubMed ID: 12969956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for lysosomal storage disorders.
    Nakamura K; Hattori K; Endo F
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chitotriosidase: a potential new marker of sarcoidosis severity.
    Bargagli E; Maggiorelli C; Rottoli P
    Respiration; 2008; 76(2):234-8. PubMed ID: 18487875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
    Tümer L; Kasapkara ÇS; Biberoğlu G; Ezgü F; Hasanoğlu A
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1149-52. PubMed ID: 23813353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly.
    vom Dahl S; Mengel E
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):619-28. PubMed ID: 20955964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of chitotriosidase isoforms in plasma of Gaucher disease patients by two dimensional gel electrophoresis.
    Quintana L; Monasterio A; Escuredo K; del Amo J; Alfonso P; Elortza F; Santa Cruz S; Simón L; Martínez A; Giraldo P; Pocoví M; Castrillo JL
    Biochim Biophys Acta; 2006 Jul; 1764(7):1292-8. PubMed ID: 16860006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic frequency determination of the 24-bp chitotriosidase duplication in the Portuguese population by real-time PCR.
    Rodrigues MR; Sá Miranda MC; Amaral O
    Blood Cells Mol Dis; 2004; 33(3):362-4. PubMed ID: 15528158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease.
    Aerts JMFG; Kuo CL; Lelieveld LT; Boer DEC; van der Lienden MJC; Overkleeft HS; Artola M
    Curr Opin Chem Biol; 2019 Dec; 53():204-215. PubMed ID: 31783225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.